Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA commissioner announcement possible before Congress adjourns, FDA's Schultz says.

Executive Summary

FDA COMMISSIONER ANNOUNCEMENT POSSIBLE BY END OF OCTOBER, Deputy Commissioner for Policy William Schultz predicted at a Food & Drug Law Institute meeting Sept. 3 in Washington, D.C. Asked to comment on the search for a new commissioner, Schultz responded: "Hopefully, there will be something announced relatively soon...before Congress goes out of session." The House and Senate both are expected to adjourn before Nov. 1. The Administration is not expected to present a nominee formally until after the FDA reform/Prescription Drug User Fee Act reauthorization bill is passed.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030784

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel